Sera from 33 persons with staphylococcal infections and from 37 healthy persons were surveyed for the presence of antibody to staphylococcal enterotoxins A, B, C, D, and E and toxic shock syndrome toxin 1. Thirty-one (93.9%) of the patients and 35 (94.6%) of the control group had antibodies to one or more of the enterotoxins. The numbers of patients with antibody to the enterotoxins were as follows: A, 8; B, 9; C, 7; D, 17; E, 21; and toxic shock syndrome toxin 1, 11. The numbers of healthy individuals with antibody to the enterotoxins were as follows: A, 6; B, 12; C, 8; D, 27; E, 21; and toxic shock syndrome toxin 1, 9.
A number of strains of staphylococci produce toxins, staphylococcal enterotoxins A (SEA), B (SEB), C (SEC), D (SED), and E (SEE), which are responsible for staphylococcal food poisoning (1) . These toxins can be involved in other types of staphylococcal illness (8, 12, 13) . Other strains of staphylococci produce a toxin, toxic shock syndrome toxin 1 (TSST-1) (M. S. Bergdoll and P. M. Schlievert, Letter, Lancet ii:691, 1984), which is the primary cause of toxic shock syndrome (TSS) (11, 14) . The prevalence of staphylococcal strains in Brazil that produce these toxins is not known, since staphylococcal food poisoning is seldom reported and no cases of TSS have been recognized. Staphylococcal infections of various types do occur, but the staphylococci involved have not been examined for the production of toxin. Evidence is available to show that individuals who have had contact with toxin-producing staphylococci carry antibody to the toxins (2, 3-5, 7, 9, 16) .
In this communication we report the incidence of toxinproducing staphylococci associated with staphylococcal infections and the immune response of these individuals to the toxins in Rio de Janeiro, Brazil. In addition, sera from healthy individuals were examined for the presence of antibody to the toxins. Media. The media used for isolating the staphylococci were blood agar base (Difco Laboratories, Detroit, Mich.) with 5% horse blood and Baird-Parker (Difco). Swabs were inoculated in both media; after incubation for 24 to 48 h, the different colonies formed on the plates were examined by Gram staining.
MATERIALS AND METHODS
Coagulase and thermonuclease. For coagulase, 0.1 ml of an overnight culture in brain heart infusion broth (Difco) was added to 0.4 ml of citrated plasma and incubated in a water bath at 37°C. Readings were made at 2, 4, 6, and 24 h. A 3+ or 4+ reaction was accepted as a positive reaction (15) . Thermonuclease was determined by the method of Lachica et al. (6) .
Toxin analysis. Toxin production was by the membraneover-agar method with detection of the toxin by the optimum-sensitivity plate method (10) .
Antibody analysis. Undiluted sera and twofold dilutions of sera were tested against purified toxins by the optimumsensitivity plate mnethod. Titers were defined as the maximum dilutions of sera that produced a precipitate line against 1.0 ,ug of toxin per ml. RESULTS S. aureus strains that produced one or more enterotoxins were isolated from 11 patients, and strains that produced TSST-1 were isolated from 5 patients (Table 1) . Non-toxinproducing strains were isolated from the other 17 patients. S. aureus strains that produced enterotoxin were isolated from five healthy persons, and strains that produced TSST-1 were isolated from four healthy persons (Table 1) . Of 29 additional healthy persons, 10 carried non-toxin-producing staphylococci.
All individuals, both patients and healthy persons, who were colonized with strains that produced toxin were seropositive for the toxin produced, with the exception of two patients with an SED-producing strain and a healthy person with a TSST-1-producing strain ( (Tables 1 and 2 ).
DISCUSSION
Only minimal information is available about the presence of antibody to staphylococcal enterotoxins in human sera. The results from the testing of S. aureus strains for production of TSST-1 showed that this toxin, which is the cause of TSS, was produced by 9 (37.5%) of the 24 toxinproducing strains, 8 producing it alone. The patients from whom these strains were isolated had antibody titers to TSST-1. This should be protective against the development of TSS (2) , and none were diagnosed as having TSS. All but one of the individuals who carried TSST-1-positive staphylococci had antibody titers to TSST-1. Others have found that individuals who are colonized with TSST-1-producing staphylococci have antibody to TSST-1 (3, 9) . However, only 20 (28.6%) of the 70 individuals examined carried antibody to TSST-1. This is much lower than the carriage of antibody to TSST-1 in individuals in the United States (16) and Germany (7); however, the method used for antibody analysis here was less sensitive than the radioimmunoassay method used in the other studies (2). The 1:1 dilution in the optimum-sensitivity plate method used is equivalent to approximately a 500 to 1,000 dilution of sera in the radioimmunoassay; however, the percentage producing this value was mugh higher (83.3%o) in the other studies than the 24.3% found in Brazil. It appears that staphylococci producing TSST-1 are not as common in Brazil as in other countries, such as the United States and Germany, and may explain in part why TSS has not been seen in Brazil. 
